Cited by 78Lipid metabolism and disordersLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes

Zannis, Vassilis I., Kardassis, Dimitris, Zanni, Eleni Economou·1993·Advances in Human Genetics 21

Integrity signals

Registry

Crossref · 10.1007/978-1-4615-3010-7_3

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutations in the 136-150 region of the N-terminal domain of apoE reduce LDL receptor binding capacity and have been linked with lipoprotein disorders such as type III hyperlipoproteinemia in humans.

    “Mutations in the 136–150 region of the N-terminal domain of apoE, reduce its low density lipoprotein (LDL) receptor binding capacity and have been linked with lipoprotein disorders, such as type III hyperlipoproteinemia (HLP) in humans.”
  • These apoE3 variants maintain their ability to predispose to type III HLP and do so in a dominant fashion, unlike apoE2.

    “Still, these variants not only maintain their ability to predispose to type III HLP, but also do so in a dominant fashion, unlike apoE2 [22], [26], [30], [31], [33], [34], [35].”
  • A variety of rare mutations in the 136-147 region of apoE are associated with a dominant mode of inheritance of type III HLP that is expressed at an early age.

    “A variety of rare mutations in the 136-147 region of apoE are associated with a dominant mode of inheritance of type III HLP that is expressed at an early age ( 7,8,12,13 ).”

The citation lists haven’t been fetched yet

References 1,044 · Cited by 78

Authors
Zannis, V. I., Kardassis, D., & Zanni, E. E.
Affiliations
Boston University (US)
Venue
Advances in Human Genetics 21
Publisher
Springer US
Published
1993
Volume
21
Pages
145-319
OpenAlex
W15063664
Cited by
78
References
1,044
Citations by year
2025: 2 · 2022: 2 · 2021: 6 · 2020: 2 · 2019: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 3
FWCI
13.34
Type
book chapter
Language
en
Open access
closed
Locations
  • Springer eBooks (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL-07224, HL-33952, T32HL007224, R01HL033952)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
genetic mutations, lipoproteins, apolipoproteins, lipoprotein receptors, chylomicrons, VLDL, low-density lipoprotein, high-density lipoprotein, intermediate density lipoprotein, apolipoprotein synthesis
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, DNA, Humans, Phosphatidylcholine-Sterol O-Acyltransferase, Lipase, Lipoprotein Lipase, Lipoproteins, Molecular Sequence Data, Mutation, Receptors, Cell Surface, Receptors, Lipoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review